BMO Capital analyst John McNulty lowered the firm’s price target on Chemours (CC) to $27 from $34 and keeps an Outperform rating on the shares ...
As a Wii U title, it was underplayed but highly praised, so a Switch release makes sense, and the game certainly shines by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback